On Air Now

Listen

Listen Live Now » 98.5 FM Battle Creek, Michigan

Weather

Current Conditions(Battle Creek,MI 49017)

More Weather »
74° Feels Like: 74°
Wind: SSW 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 55°

Tomorrow

Partly Cloudy 77°

Fri Night

Thundershowers 65°

Alerts

Roche says Kadcyla wins European approval

The logo of Swiss pharmaceutical company Roche is seen at a plant in the central Swiss village of Rotkreuz November 6, 2013. REUTERS/Arnd Wi
The logo of Swiss pharmaceutical company Roche is seen at a plant in the central Swiss village of Rotkreuz November 6, 2013. REUTERS/Arnd Wi

ZURICH (Reuters) - Roche said on Wednesday its drug Kadcyla, a treatment for an aggressive form of breast cancer, had been approved in Europe following U.S. approval in February.

Kadcyla treats patients with late-stage disease whose cancer cells contain increased amounts of a protein known as HER2.

It works by attaching Herceptin to a drug called DM1, developed by ImmunoGen, which interferes with cancer cell growth. ImmunoGen will receive a $5 million milestone payment from Roche following the approval.

(This story corrects to remove reference to Japan approval from the third paragraph)

(Reporting By Katharina Bart; Editing by Andrew Heavens and Louise Heavens)

Comments